Kanbay, Mehmet
Siriopol, Dimitrie
Copur, Sidar
Hasbal, Nuri Baris
Güldan, Mustafa
Kalantar-Zadeh, Kam
Garfias-Veitl, Tania
von Haehling, Stephan
Funding for this research was provided by:
Herzzentrum Göttingen
Article History
Received: 25 March 2024
Accepted: 30 July 2024
First Online: 9 September 2024
Declarations
:
: Dr Kalantar has received honoraria from Fresenius, DaVita, CSL, GSK. Dr. S.v.H. has been a paid consultant for and/or received honoraria payments from Amomed, AstraZeneca, Bayer, Boehringer Ingelheim, BRAHMS, Edwards Lifesciences, MSD, Novartis, Pfizer, Pharmacosmos, Respicardia, Roche, Servier, Sorin, and Vifor. S.v.H. reports research support from Amgen, AstraZeneca, Boehringer Ingelheim, Pharmacosmos, IMI, and the German Center for Cardiovascular Research (DZHK). Other Authors declare that they have no conflict of interest.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: For this type of study, formal consent is not required.